Recent CNS/Neurology Research for December 2024
The World Market for Opium Alkaloids, Their Derivatives, and Salts Thereof: A 2022 Global Trade Perspective
Topics: Manufacturing, Packaging & Detailing, CNS/Neurology
Regions: Global
| Pharmaceuticals Industry Deals and Trends in May 2021 - Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
Topics: Pharmaceuticals Company Reports, Manufacturing, Packaging & Detailing, Drug Discovery, Infectious Diseases, CNS/Neurology
| Migraine - Epidemiology Forecast to 2030
Topics: Pain, Prescription Drugs, Drug Discovery, CNS/Neurology
| Depression (Central Nervous System) - Drugs In Development, 2021
Topics: Mental Health, Drug Discovery, CNS/Neurology, Behavioral Health
| Anesthetic Effect (Central Nervous System) - Drugs In Development, 2021
Topics: Drug Discovery, CNS/Neurology
| Mild Cognitive Impairment (Central Nervous System) - Drugs In Development, 2021
Topics: Drug Discovery, CNS/Neurology
| Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) - Drugs In Development, 2021
Topics: Drug Discovery, CNS/Neurology
| Dyskinesia (Central Nervous System) - Drugs In Development, 2021
Topics: Drug Discovery, CNS/Neurology
| Opium (Opioid) Addiction (Central Nervous System) - Drugs In Development, 2021
Topics: Drug Discovery, CNS/Neurology
| Osteoarthritis Pain (Central Nervous System) - Drugs In Development, 2021
Topics: Pain, Arthritis, Osteoporosis, Drug Discovery, CNS/Neurology
| Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Discovery, CNS/Neurology
| Bipolar Disorder - Epidemiology Forecast to 2030
Topics: Prescription Drugs, CNS/Neurology, Behavioral Health
| Pontine Glioma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology, Oncology/Hematology
| Neuromyelitis Optica Spectrum Disorder - Opportunity Assessment and Forecast to 2030
Topics: Autoimmune, Drug Discovery, CNS/Neurology
| Migraine - Global Drug Forecast and Market Analysis to 2030
Topics: Pain, Research & Development, Drug Discovery, CNS/Neurology
Regions: Global
| Canavan Disease (Central Nervous System) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, CNS/Neurology
| Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, CNS/Neurology
| Huntington Disease (Central Nervous System) - Drugs in Development, 2021
Topics: Huntington's, Research & Development, Prescription Drugs, Drug Discovery, CNS/Neurology
| Progressive Supranuclear Palsy (Central Nervous System) - Drugs in Development, 2021
Topics: Research & Development, Prescription Drugs, Drug Discovery, CNS/Neurology
| Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021
Topics: Drug Discovery, CNS/Neurology
| Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, CNS/Neurology
Regions: Global
| Autism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology, Behavioral Health
| Obsessive-Compulsive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology, Behavioral Health
| Post-Traumatic Stress Disorder (PTSD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology, Behavioral Health
| Traumatic Brain Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Diabetic Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Diabetes, Drug Discovery, CNS/Neurology
| Drug Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Epilepsy, Prescription Drugs, Drug Discovery, CNS/Neurology
| Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Research & Development, Prescription Drugs, Drug Discovery, CNS/Neurology, Behavioral Health
| Spinal Muscular Atrophy (SMA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Gene Therapy, Drug Discovery, CNS/Neurology
| Opium (Opioid) Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Tinnitus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Narcolepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Pain, Drug Discovery, CNS/Neurology
| Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Topics: Drug Discovery, Clinical Trial, CNS/Neurology
| Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031
Topics: Drug Discovery, CNS/Neurology, Behavioral Health
| Progressive Multifocal Leukoencephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Anaplastic Astrocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Gliosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, CNS/Neurology
| Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs
Topics: Pain, Manufacturing, Packaging & Detailing, CNS/Neurology
Regions: Global
| The 2023-2028 World Outlook for Addiction Treatments
Topics: Prescription Drugs, CNS/Neurology
Regions: Global
| Post-Operative Pain (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Pain, Drug Discovery, CNS/Neurology
| Obsessive-Compulsive Disorder (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology, Behavioral Health
| Traumatic Brain Injury (Central Nervous System) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Diabetic Peripheral Neuropathy (Metabolic Disorder) - Drugs in Development, 2021
Topics: Drug Development, Diabetes, Drug Discovery, CNS/Neurology, Endocrinology/Metabolics
|
Prev | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
